Future Market Insights (FMI) predicts that the global Cell Culture Media Bags Market will grow at a stellar CAGR of 10.8% between 2022 and 2030 in its new market study. Furthermore, the study predicts that by 2030, the market will have surpassed a global valuation of US$ 2.67 Bn. The report attributes the market’s expansion to rising demand for disposable packaging solutions in life sciences R&D activities and biopharmaceutical manufacturing.

Furthermore, the emergence of novel techniques such as four-layered films with exceptional oxygen and moisture barrier properties is expected to drive demand.

Get Sample PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-12670

After assessing the impact of the COVID-19 pandemic, the report concludes that rising health concerns and a focus on biopharmaceutical research bode well for market growth during the assessment period.

COVID-19 Impact

The COVID-19 outbreak is expected to boost demand for cell culture media bags, as players in the healthcare and pharmaceutical sectors place a premium on high-quality and secure packaging and storage solutions. Furthermore, an increase in the number of studies and researches to develop a vaccine during the pandemic is driving demand for cell culture media bags.

Similarly, the need for disposable and single-use solutions in the biopharmaceutical market for applications such as large-scale purification, cell storage, protein purification, and polishing will continue to provide lucrative opportunities to market players throughout the pandemic period.

List of Key Players Covered in Cell Culture Media Bags Market are:

  • Parker Hannifin Corp
  • Pall Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • GE Healthcare Inc.

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-12670

Competitive Landscape:

Partnerships and collaborations, product launches, expansions, and other strategies have been used to gain a significant share of the cell culture media bags market in this rapidly growing industry.

Market participants are focusing on upscaling media bag production to meet the increased demand for bioprocess manufacturing activities. Furthermore, manufacturers are addressing issues and improving bag features such as four-layered films that provide stronger oxygen and moisture barriers to the properties.

In this vein, Thermo Fisher Scientific released the CEDIA Mitragynine (Kratom) Assay, a novel immunoassay for kratom alkaloid mitragynine screening designed specifically for criminal justice and forensic purposes.Throughout the projection period, continuous product innovations will continue to define the competitive landscape of the market. Furthermore, industry participants are concentrating their efforts on producing products for specific end uses.

Key Takeaways

  • Due to their high flexibility, 2D bag designs are expected to account for more than half of the market value.
  • Because of their low contamination properties, very large bags (>3000 ml) will continue to be the most popular size.
  • The bacterial cell segment is expected to account for the majority of market value, owing to an increasing number of studies on bacteria-caused diseases.
  • Biopharmaceutical manufacturing will continue to be a key end-use segment, accounting for more than two-thirds of market value over the forecast period.
  • US will remain the largest market for cell culture media bags globally.

“Market players are investing in new product innovation and are focusing on procuring FDA approvals to facilitate wide-scale deployment,” remarks FMI analyst.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-12670

Who is Winning?

Cell culture media bags manufacturers are focusing on developing solutions that address the key challenges such as recycling of multilayer flexible packaging consisting of plastic and barrier materials. Moreover, new product development and strategic partnerships have been identified as key growth strategies adopted by market players.

  • In April 2019, Thermo Fisher Scientific launched a new immunoassay – CEDIA Mitragynine (Kratom) Assay – for kratom alkaloid mitragynine screening solely for criminal justice and forensic applications.
  • In August, 2015, Rim Bio partnered with Playmouth based Sentrol for sales and distribution of its single-use bio containers across the United States.

FMI’s report includes profiles of some of the most prominent names in the market including Parker Hannifin Corp, Pall Corporation, Sartorious AG, Thermo Fisher Scientific Inc., and GE Healthcare Inc.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Чтобы увидеть, как блондинка дрочит клитор стоит перейти по ссылке и насладиться этим зрелищем

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Leave a comment

Your email address will not be published. Required fields are marked *